UBS and Craig-Hallum maintained a Buy rating on Docebo Inc. (DCBO) on March 02, 2026. The DCBO analyst rating stayed at Buy even as both firms trimmed price targets after Docebo’s Q4 results. StreetInsider headlines noted a $36 price target tied to Canaccord commentary and a $38 price target from Craig-Hallum, while the stock moved modestly on the news.
DCBO analyst rating summary
On March 02, 2026 at 10:54 AM, UBS maintained a Buy rating; StreetInsider published a headline noting a $36 price target linked to Canaccord commentary source.
Analyst actions and price targets
On March 02, 2026 at 10:02 AM, Craig-Hallum maintained a Buy rating and lowered its price target to $38, according to StreetInsider source.
Market reaction to the maintained buys
The two notes produced small stock moves: one showed a +0.98% ($0.17) change and the other -0.51% ($-0.09), reflecting a muted investor response to price target trims.
What the ratings mean for investors
Maintained Buy ratings signal that both firms see long-term upside, despite near-term pressure on forecasts after Q4. Investors should weigh the trimmed DCBO price target guidance against Docebo’s growth profile and execution risk.
Historical analyst coverage and context
Analyst coverage for Docebo has included Canaccord, Craig-Hallum, and UBS in recent cycles, with periodic target resets after quarterly reports. The two March 02, 2026 notes continue a pattern of Buy-aligned coverage with evolving price targets.
Meyka grade and outlook
Meyka AI rates DCBO with a grade of A. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s real-time tools note the maintained Buy ratings as positive for institutional sentiment, though trimmed targets lower near-term upside estimates.
Final Thoughts
Key takeaways: on March 02, 2026, UBS and Craig-Hallum both maintained Buy ratings on Docebo Inc. (DCBO) while lowering price targets to $36 (reference to Canaccord commentary) and $38 respectively. The two reports produced limited share movement, with recorded changes of +0.98% ($0.17) and -0.51% ($-0.09), suggesting the market viewed these notes as calibrated updates rather than directional shocks. For investors, maintained Buy ratings imply continued analyst confidence in Docebo’s secular growth in learning management systems, but the trimmed DCBO price target levels highlight near-term margin and guidance risks tied to recent Q4 results. Given a market cap of $507,903,757, Docebo sits in a mid-cap range where earnings execution matters for multiple re-ratings. We recommend investors consider these analyst views alongside company fundamentals, recent Q4 metrics, and portfolio time horizon. Use Meyka AI’s platform for real-time analyst coverage and to track future changes to the DCBO analyst rating
FAQs
What did the March 02, 2026 notes say about Docebo’s price targets?
StreetInsider reported a $36 price target referenced with Canaccord commentary and a $38 target from Craig-Hallum on March 02, 2026. Both firms maintained a Buy rating while trimming near-term estimates.
Does a maintained Buy mean the stock will rise?
A maintained Buy means the analysts still see upside, but it is not a guarantee of immediate gains. Investors should combine the DCBO analyst rating with fundamentals, Q4 results, and risk tolerance before acting.
How does Meyka view these rating updates for DCBO?
Meyka AI rates DCBO with a grade of A; we see the maintained Buy ratings as supportive for sentiment, though trimmed price targets lower short-term upside and call for monitoring execution and guidance.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
